Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Kulmala

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurochemical Pathology|January 1, 1985
Some enkephalin- or VIP-immunoreactive hippocampal pyramidal cells contain neurofibrillary tangles in the brains of aged humans and persons with Alzheimer's diseaseH K Kulmala
Neuropathology and Applied Neurobiology|March 1, 1985
Immunocytochemical localization of enkephalin-like immunoreactivity in neurons of human hippocampal formation: effects of ageing and Alzheimer's diseaseH K Kulmala
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Role of the senile plaque in neuropeptide deficits of Alzheimer's diseaseH K Kulmala, J T Hutton
Life Sciences|September 14, 1987
Behavioral suppression following 3,4-methylenenedioxymethamphetamineH K Kulmala, J W Boja, M D Schechter
Brain Research Bulletin|May 1, 1987
A novel, adaptable and inexpensive computerized activity meterH K Kulmala, J W Boja, J T Hutton
Life Sciences|April 27, 1981
Specific in vivo binding of 77Br-p-bromospiroperidol in rat brain: a potential tool for gamma ray imagingH K Kulmala, C C Huang, R J Dinerstein, et al.
Experimental Aging Research|January 1, 1987
Brain reactive antibodies and the blood-brain barrier: observations in aging rodents and the effects of peripheral kainic acidH K Kulmala, J W Boja, J W Albrecht, et al.
Biopharmaceutics & Drug Disposition|April 1, 1992
Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteersG A Thompson, J A Smithers, M T Kenny, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurochemical Pathology|January 1, 1985
Some enkephalin- or VIP-immunoreactive hippocampal pyramidal cells contain neurofibrillary tangles in the brains of aged humans and persons with Alzheimer's diseaseH K Kulmala
Neuropathology and Applied Neurobiology|March 1, 1985
Immunocytochemical localization of enkephalin-like immunoreactivity in neurons of human hippocampal formation: effects of ageing and Alzheimer's diseaseH K Kulmala
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Role of the senile plaque in neuropeptide deficits of Alzheimer's diseaseH K Kulmala, J T Hutton
Life Sciences|September 14, 1987
Behavioral suppression following 3,4-methylenenedioxymethamphetamineH K Kulmala, J W Boja, M D Schechter
Brain Research Bulletin|May 1, 1987
A novel, adaptable and inexpensive computerized activity meterH K Kulmala, J W Boja, J T Hutton
Life Sciences|April 27, 1981
Specific in vivo binding of 77Br-p-bromospiroperidol in rat brain: a potential tool for gamma ray imagingH K Kulmala, C C Huang, R J Dinerstein, et al.
Experimental Aging Research|January 1, 1987
Brain reactive antibodies and the blood-brain barrier: observations in aging rodents and the effects of peripheral kainic acidH K Kulmala, J W Boja, J W Albrecht, et al.
Biopharmaceutics & Drug Disposition|April 1, 1992
Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteersG A Thompson, J A Smithers, M T Kenny, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteersJ A Smithers, H K Kulmala, G A Thompson, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1J A Smithers, G A Thompson, M T Kenny, et al.
Pageof 1